Positive results for Progenza in treating neuropathic pain
Filed with ASX · · 3 pages · English
Story so far
Earlier from Cambium Bio
- Directors Provide $2.5M Loan to Extend Funding Runway
- Response to ASX Appendix 4C Query Letter
- New CEO Appointed to Accelerate Global Growth
- Chinese patent granted for biomarkers for stem cell therapy
- Re-Released - Appendix 4C - Quarterly
Later from Cambium Bio
- Successful Private Placement
- Investor Presentation
- Offer Booklet
- Updated Investor Presentation
- Restructuring results in 50% reduction in operating costs
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio